Latest News in the pharma Industry

Biopharma News

Sanofi galvanizes strategic product pipeline with Principia Biopharma acquisition

Sanofi galvanizes strategic product pipeline with Principia Biopharma acquisition

17 Aug 2020

The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases.

Read more 
Samsung Biologics adds fourth plant due to growing demand

Samsung Biologics adds fourth plant due to growing demand

11 Aug 2020

Plant 4 will add 256 KL capacity to its site, which is scheduled to commence manufacturing activities in the second half of 2022.

Read more 
Moderna inks US deal for 100 million doses of its COVID vaccine

Moderna inks US deal for 100 million doses of its COVID vaccine

11 Aug 2020

The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light.

Read more 
Lonza expands microbial capacity and extends partnership with Servier for L-asparaginase API manufacturing

Lonza expands microbial capacity and extends partnership with Servier for L-asparaginase API manufacturing

4 Aug 2020

New mid-scale microbial facility will support Servier with API for acute lymphoblastic leukemia therapies.

Read more 
Oxford Biomedica signs 3-year CSA for Parkinson’s disease gene therapy program

Oxford Biomedica signs 3-year CSA for Parkinson’s disease gene therapy program

3 Aug 2020

The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities.

Read more 
Sanofi and GSK in advanced discussions with EU to supply up to 300 million doses of COVID-19 vaccine

Sanofi and GSK in advanced discussions with EU to supply up to 300 million doses of COVID-19 vaccine

3 Aug 2020

Discussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system.

Read more 
Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate

Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate

3 Aug 2020

The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021.

Read more 
Samsung Biologics invests in expanding aseptic filling capacity at Incheon site

Samsung Biologics invests in expanding aseptic filling capacity at Incheon site

21 Jul 2020

Through this expansion, the CDMO will increase the total lyophilization capacity by 246% of the current capacity.

Read more 
Catalent to create European clinical manufacturing center of excellence in France

Catalent to create European clinical manufacturing center of excellence in France

21 Jul 2020

The $30 million investment will enable the site to handle large-molecule programs, with additional capacity for small molecule dosage form development.

Read more 
Stevanato Group and Colanar colaborate to study container closure systems

Stevanato Group and Colanar colaborate to study container closure systems

21 Jul 2020

The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization.

Read more 
Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate

Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate

20 Jul 2020

Data on the first clinical use of lenzilumab in patients with severe COVID-19 pneumonia suggest promising results.

Read more 
ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution

ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution

14 Jul 2020

Sterile transfer solutions without compromising operational efficiency.

Read more